Cambridge Investment Research Advisors, Inc. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$302
-1.6%
6,647
-11.1%
0.00%0.0%
Q2 2023$307
+1.3%
7,474
-11.8%
0.00%0.0%
Q1 2023$303
-16.1%
8,474
-11.3%
0.00%
-50.0%
Q4 2022$361
-99.9%
9,555
-12.5%
0.00%
-33.3%
Q3 2022$483,000
+17.2%
10,922
-1.8%
0.00%
+50.0%
Q2 2022$412,000
+6.2%
11,122
+6.3%
0.00%0.0%
Q1 2022$388,000
+22.0%
10,467
+0.2%
0.00%
+100.0%
Q4 2021$318,000
-43.8%
10,447
-38.1%
0.00%
-66.7%
Q3 2021$566,000
-26.4%
16,867
-12.5%
0.00%
-25.0%
Q2 2021$769,000
+14.9%
19,274
+29.6%
0.00%0.0%
Q1 2021$669,000
+193.4%
14,877
+294.3%
0.00%
+100.0%
Q4 2019$228,000
+9.6%
3,773
+8.8%
0.00%0.0%
Q3 2019$208,000
-6.7%
3,468
+0.1%
0.00%0.0%
Q2 2019$223,000
-21.8%
3,464
-1.3%
0.00%
-33.3%
Q1 2019$285,000
-8.7%
3,511
-41.9%
0.00%0.0%
Q3 2018$312,000
+47.2%
6,045
+18.6%
0.00%
+50.0%
Q2 2018$212,000
-14.2%
5,096
+4.5%
0.00%
-33.3%
Q3 2017$247,000
+11.3%
4,875
+11.8%
0.00%0.0%
Q2 2017$222,000
-17.5%
4,362
-22.3%
0.00%
-40.0%
Q4 2016$269,000
+17.5%
5,616
-10.1%
0.01%
+25.0%
Q3 2016$229,000
-9.1%
6,248
+0.4%
0.00%
-33.3%
Q1 2016$252,000
-41.3%
6,221
-10.3%
0.01%
-40.0%
Q4 2015$429,0006,9350.01%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders